Asked by: Kirsten Oswald (Scottish National Party - East Renfrewshire)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, what the cost to the public purse was of Government investment into kidney disease research in 2022-23; and which public bodies provided that investment.
Answered by Andrew Griffith - Shadow Secretary of State for Business and Trade
UK Research and Innovation (UKRI) funds research into the detection, prevention, treatment and underpinning biology of kidney disease, allocated primarily through the Medical Research Council (MRC). Over the period of 2019/20 to 2022/23, MRC has invested nearly £30 million in funding and support for kidney disease research with £6.9 million in 2022/23.
The National Institute for Health and Care Research (NIHR) also provides funding for kidney disease research. I refer the Hon. Member to the answer provided by my Rt. Hon. Friend the member for Pendle on 15 April 2024 (UIN 20328).
https://questions-statements.parliament.uk/written-questions/detail/2024-03-25/20328
Asked by: Kirsten Oswald (Scottish National Party - East Renfrewshire)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, if she will take steps to ensure that female patients are included in (a) medical research and (b) clinical trials for (i) dementia and (ii) early on-set Alzheimer's disease funded by her Department.
Answered by Andrew Griffith - Shadow Secretary of State for Business and Trade
UKRI, through the Medical Research Council is working to ensure that female patients are included in medical research and clinical trials for all conditions, including by instituting a requirement for both sexes to be included in research studies by default. MRC's embedding diversity in research design policy requires researchers to consider characteristics such as gender, age and ethnicity - as well as sex - in their projects. MRC is working with the MESSAGE (Medical Science Sex and Gender Equality) initiative to co-design a sex and gender policy framework which could guide organisations throughout the health and biomedical research sector.